Metastatic castration‐sensitive prostate cancer: Abiraterone, docetaxel, or von Barata, Pedro C., Sartor, A. Oliver

Volltext

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial von de Bono, Johann Sebastian, Dr, Oudard, Stephane, MD, Ozguroglu, Mustafa, MD, Hansen, Steinbjørn, MD, Machiels, Jean-Pascal, MD, Kocak, Ivo, MD, Gravis, Gwenaëlle, MD, Bodrogi, Istvan, MD, Mackenzie, Mary J, MD, Shen, Liji, PhD, Roessner, Martin, MS, Gupta, Sunil, MD, Sartor, A Oliver, MD

Volltext

Germline BLM mutations and metastatic prostate cancer von Ledet, Elisa M., Antonarakis, Emmanuel S., Isaacs, William B., Lotan, Tamara L., Pritchard, Colin, Sartor, A. Oliver

Volltext

Real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer von Higano, Celestia S., Armstrong, Andrew J., Sartor, A. Oliver, Vogelzang, Nicholas J., Kantoff, Philip W., McLeod, David G., Pieczonka, Christopher M., Penson, David F., Shore, Neal D., Vacirca, Jeffrey, Concepcion, Raoul S., Tutrone, Ronald F., Nordquist, Luke T., Quinn, David I., Kassabian, Vahan, Scholz, Mark C., Harmon, Matt, Tyler, Robert C., Chang, Nancy N., Tang, Hong, Cooperberg, Matthew R.

Volltext

PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label singl... von Petrylak, Daniel P., Vogelzang, Nicholas J., Chatta, Kamal, Fleming, Mark T., Smith, David C., Appleman, Leonard J., Hussain, Arif, Modiano, Manuel, Singh, Parminder, Tagawa, Scott T., Gore, Ira, McClay, Edward F., Mega, Anthony E., Sartor, A. Oliver, Somer, Bradley, Wadlow, Raymond, Shore, Neal D., Olson, William C., Stambler, Nancy, DiPippo, Vincent A., Israel, Robert J.

Volltext

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer von Armstrong, Andrew J, Eisenberger, Mario A, Halabi, Susan, Oudard, Stephane, Nanus, David M, Petrylak, Daniel P, Sartor, A. Oliver, Scher, Howard I

Volltext

A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer von George, Daniel J., Halabi, Susan, Heath, Elisabeth I., Sartor, A. Oliver, Sonpavde, Guru P., Das, Devika, Bitting, Rhonda L., Berry, William, Healy, Patrick, Anand, Monika, Winters, Carol, Riggan, Colleen, Kephart, Julie, Wilder, Rhonda, Shobe, Kellie, Rasmussen, Julia, Milowsky, Matthew I., Fleming, Mark T., Bearden, James, Goodman, Michael, Zhang, Tian, Harrison, Michael R., McNamara, Megan, Zhang, Dadong, LaCroix, Bonnie L., Kittles, Rick A., Patierno, Brendon M., Sibley, Alexander B., Patierno, Steven R., Owzar, Kouros, Hyslop, Terry, Freedman, Jennifer A., Armstrong, Andrew J.

Volltext

Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space von Sartor, A Oliver

Volltext

A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches von Chabner, Bruce A., Bates, Susan E., Fojo, Antonio Tito, Murphy, Ann, Sartor, A. Oliver, Murphy, Martin J.

Volltext

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study von Smith, Matthew R, Sweeney, Christopher J, Corn, Paul G, Rathkopf, Dana E, Smith, David C, Hussain, Maha, George, Daniel J, Higano, Celestia S, Harzstark, Andrea L, Sartor, A Oliver, Vogelzang, Nicholas J, Gordon, Michael S, de Bono, Johann S, Haas, Naomi B, Logothetis, Christopher J, Elfiky, Aymen, Scheffold, Christian, Laird, A Douglas, Schimmoller, Frauke, Basch, Ethan M, Scher, Howard I

Volltext

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Onc... von Rosenthal, Seth A., MD, Hunt, Daniel, PhD, Sartor, A. Oliver, MD, Pienta, Kenneth J., MD, Gomella, Leonard, MD, Grignon, David, MD, Rajan, Raghu, MD, Kerlin, Kevin J., MD, Jones, Christopher U., MD, Dobelbower, Michael, MD, Shipley, William U., MD, Zeitzer, Kenneth, MD, Hamstra, Daniel A., MD, PhD, Donavanik, Viroon, MD, Rotman, Marvin, MD, Hartford, Alan C., MD, Michalski, Jeffrey, MD, Seider, Michael, MD, Kim, Harold, MD, Kuban, Deborah A., MD, Moughan, Jennifer, MS, Sandler, Howard, MD

Volltext

Urologists and oncologists: adapting to a new treatment paradigm in castration‐resistant prostate cancer (CRPC) von Sartor, A. Oliver, Fitzpatrick, John M.

Volltext

Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA von Bennett, Charles L, Sartor, Oliver A, Armitage, James O, Kantarjian, Hagop

Volltext

Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometast... von Reyes, Diane K., Trock, Bruce J., Tran, Phuoc T., Pavlovich, Christian P., Deville, Curtiland, Allaf, Mohamad E., Greco, Stephen C., Song, Daniel Y., Bivalacqua, Trinity J., Han, Misop, Partin, Alan W., Sartor, A. Oliver, Rowe, Steven P., Pienta, Kenneth J.

Volltext

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy‐Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions von Bennett, Charles L., Nagai, Sumimasa, Bennett, Andrew C., Hoque, Shamia, Nabhan, Chadi, Schoen, Martin W., Hrushesky, William J., Luminari, Stefano, Ray, Paul, Yarnold, Paul R., Witherspoon, Bart, Riente, Josh, Bobolts, Laura, Brusk, John, Tombleson, Rebecca, Knopf, Kevin, Fishman, Marc, Yang, Y. Tony, Carson, Kenneth R., Djulbegovic, Benjamin, Restaino, John, Armitage, James O., Sartor, Oliver A.

Volltext

The current role and limitations of surrogate endpoints in advanced prostate cancer von Gomella, Leonard G., M.D, Oliver Sartor, A., M.D

Volltext

Surveillance for prostate cancer: are the proceduralists running amok? von Sartor, A Oliver

Volltext

The association between germline BRCA2 variants and sensitivity to platinum‐based chemotherapy among men with metastatic prostate cancer von Pomerantz, Mark M., Spisák, Sandor, Jia, Li, Cronin, Angel M., Csabai, Istvan, Ledet, Elisa, Sartor, A. Oliver, Rainville, Irene, O'Connor, Edward P., Herbert, Zachary T., Szállási, Zoltan, Oh, William K., Kantoff, Philip W., Garber, Judy E., Schrag, Deborah, Kibel, Adam S., Freedman, Matthew L.

Volltext

Cytokine genetic polymorphisms and prostate cancer aggressiveness von Zabaleta, Jovanny, Su, L. Joseph, Lin, Hui-Yi, Sierra, Rosa A., Hall, M. Craig, Sartor, A. Oliver, Clark, Peter E., Hu, Jennifer J., Ochoa, Augusto C.

Volltext

A Case Report with Severe Thrombocytopenia Induced by Axitinib von Barata, Pedro C., Belyaeva, Elizaveta, Sartor, Oliver A., Lewis, Brian, Goffin, Janeiro Valle, Koksal, Ulkuhan I., Socola, Francisco

Volltext